This statistic displays the number of gene therapies and stem-cell therapies that were currently in clinical development as of 2017, by developer. According to the data, of the gene therapies in clinical development, only ** were developed by Big Pharma.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Roland Berger. (September 26, 2017). Number of stem-cell and gene therapies in current development as of 2017, by developer [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/800717/number-of-biotech-therapies-in-development-by-developer/
Roland Berger. "Number of stem-cell and gene therapies in current development as of 2017, by developer." Chart. September 26, 2017. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/800717/number-of-biotech-therapies-in-development-by-developer/
Roland Berger. (2017). Number of stem-cell and gene therapies in current development as of 2017, by developer. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/800717/number-of-biotech-therapies-in-development-by-developer/
Roland Berger. "Number of Stem-cell and Gene Therapies in Current Development as of 2017, by Developer." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Sep 2017, /statistics/800717/number-of-biotech-therapies-in-development-by-developer/
Roland Berger, Number of stem-cell and gene therapies in current development as of 2017, by developer ÌÇÐÄÆƽâ°æ, /statistics/800717/number-of-biotech-therapies-in-development-by-developer/ (last visited July 23, 2026)
Number of stem-cell and gene therapies in current development as of 2017, by developer [Graph], Roland Berger, September 26, 2017. [Online]. Available: /statistics/800717/number-of-biotech-therapies-in-development-by-developer/
